Egetis Therapeutics AB (LTS:0ABW) Cyclically Adjusted Book per Share: kr3.84 (As of Mar. 2026)


LTS:0ABW Egetis Therapeutics AB LTS:0ABW
59 GF Score
Price kr5.91
GF Value kr5.61
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Egetis Therapeutics AB Cyclically Adjusted Book per Share?

Egetis Therapeutics AB LTS:0ABW +1.29% 59 Cyclically Adjusted Book per Share is kr3.84 as of Mar. 2026. GuruFocus rates LTS:0ABW with a GF Score™ of 59/100 and a GF Value™ of kr5.61 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Egetis Therapeutics AB's adjusted book value per share for the three months ended in Mar. 2026 was kr0.629. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr3.84 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Egetis Therapeutics AB's average Cyclically Adjusted Book Growth Rate was -3.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -0.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Egetis Therapeutics AB was 5.70% per year. The lowest was -0.60% per year. And the median was 4.85% per year.

As of today (2026-07-07), Egetis Therapeutics AB's current stock price is kr5.91. Egetis Therapeutics AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr3.84. Egetis Therapeutics AB's Cyclically Adjusted PB Ratio of today is 1.54.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Egetis Therapeutics AB was 5.28. The lowest was 0.77. And the median was 1.47.


Egetis Therapeutics AB  (LTS:0ABW) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Egetis Therapeutics AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=5.91/3.84
=1.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Egetis Therapeutics AB was 5.28. The lowest was 0.77. And the median was 1.47.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Egetis Therapeutics AB Cyclically Adjusted Book per Share Related Terms


Egetis Therapeutics AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Egetis Therapeutics AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egetis Therapeutics AB Cyclically Adjusted Book per Share Chart

Egetis Therapeutics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 4.02 4.02 3.83

Egetis Therapeutics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.80 3.80 3.94 3.83 3.84

LTS:0ABW vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Egetis Therapeutics AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Egetis Therapeutics AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Egetis Therapeutics AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Egetis Therapeutics AB's Cyclically Adjusted PB Ratio falls into.


LTS:0ABW
59GF Score
Egetis Therapeutics AB LTS:0ABW
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Egetis Therapeutics AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Egetis Therapeutics AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.629/133.5600*133.5600
=0.629

Current CPI (Mar. 2026) = 133.5600.

Egetis Therapeutics AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.930 101.019 1.230
201609 0.677 101.138 0.894
201612 7.238 102.022 9.476
201703 7.009 102.022 9.176
201706 6.733 102.752 8.752
201709 6.229 103.279 8.055
201712 5.643 103.793 7.261
201803 5.349 103.962 6.872
201806 4.825 104.875 6.145
201809 4.487 105.679 5.671
201812 4.075 105.912 5.139
201903 4.504 105.886 5.681
201906 5.063 106.742 6.335
201909 4.525 107.214 5.637
201912 4.136 107.766 5.126
202003 3.413 106.563 4.278
202006 2.804 107.498 3.484
202009 2.389 107.635 2.964
202012 3.506 108.296 4.324
202103 3.393 108.360 4.182
202106 3.204 108.928 3.929
202109 3.082 110.338 3.731
202112 2.929 112.486 3.478
202203 2.774 114.825 3.227
202206 2.959 118.384 3.338
202209 2.715 122.296 2.965
202212 2.359 126.365 2.493
202303 2.519 127.042 2.648
202306 2.207 129.407 2.278
202309 1.871 130.224 1.919
202312 1.865 131.912 1.888
202403 1.615 132.205 1.632
202406 1.372 132.716 1.381
202409 1.089 132.304 1.099
202412 1.372 132.987 1.378
202503 1.206 132.825 1.213
202506 0.988 133.699 0.987
202509 0.772 133.480 0.772
202512 0.857 133.390 0.858
202603 0.629 133.560 0.629

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr3.84 mean?
Egetis Therapeutics AB (LTS:0ABW) has a Cyclically Adjusted Book per Share of kr3.84 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Egetis Therapeutics AB and its competitors.
Is Egetis Therapeutics AB's Cyclically Adjusted Book per Share too high?
Egetis Therapeutics AB's current Cyclically Adjusted Book per Share is kr3.84. Overall, Egetis Therapeutics AB has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Egetis Therapeutics AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Egetis Therapeutics AB's Cyclically Adjusted Book per Share of kr3.84 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Egetis Therapeutics AB and its competitors. Egetis Therapeutics AB's current Cyclically Adjusted Book per Share is kr3.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Egetis Therapeutics AB stock overvalued right now?
Based on GuruFocus' analysis, Egetis Therapeutics AB (LTS:0ABW) is currently considered Fairly Valued. The stock's GF Value™ is kr5.61, compared to a current price of kr5.91 — trading 5.3% above its estimated fair value. The current Cyclically Adjusted Book per Share is kr3.84. Egetis Therapeutics AB's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Egetis Therapeutics AB (LTS:0ABW), the current Cyclically Adjusted Book per Share is kr3.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Egetis Therapeutics AB (LTS:0ABW) Overvalued in 2026?

Based on GuruFocus' analysis, Egetis Therapeutics AB stock appears to be overvalued. The current stock price of kr5.91 is trading 5.3% above its estimated GF Value™ of kr5.61. GuruFocus considers Egetis Therapeutics AB to be Fairly Valued.

Key valuation signals for LTS:0ABW:

  • Cyclically Adjusted Book per Share: kr3.84
  • GF Value™: kr5.61 vs. price of kr5.91 (5.3% above fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the LTS:0ABW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Egetis Therapeutics AB Business Description

Address Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.
59GF Score

Get the complete analysis for LTS:0ABW

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.91
Price
kr5.61
GF Value